Clinical Trials · NCT03645408
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Boston Medical Center
- Enrollment
- 8
- Start date
- May 2019
- Locations
- 1 site, United States
- Primary endpoint
- Alcohol Consumption